Synthesis and psychotropic activity of N-arylacetylformamidoxime hydrazones

Poplavskaya, I. A.; Kurmangalieva, R. G.; Khalilova, S. F.; Zaks, A. S.; Kapitonenko, T. A.

doi:10.1007/bf00765163

Cited by 1 publication

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Heteroaryl acetamidoximes bearing an indolyl, isoindolyl or benzimidazolyl group, as well as heteroaryloxyacet-or propionamidoximes bearing a quinolyl, isoquinolyl, indolyl, carbazolyl or indanyl moiety and their naphthyl analogues acted as antidepressants [281,282]. Moreover, the hydrazones of several N-arylacetylformamidoximes 301, Scheme 48, exhibited central nervous system activity in mice [283]. Studies on [2-(2-phenylthio)phenyl]-acetamidoxime 291 (Scheme 47), proved that reserpine ptosis in mice and inhibition of the hypothermic effect of recerpine were effectively antagonized in the intraperitoneal dose of 5 mg/kg [267].…”

Section: Iv11 Anxiolytics-antidepressantsmentioning

confidence: 99%

Recent Developments in the Chemistry and in the Biological Applications of Amidoximes

Fylaktakidou¹,

Hadjipavlou‐Litina

Litinas³

et al. 2008

CPD

View full text Add to dashboard Cite

Amidoximes are compounds bearing both a hydroxyimino and an amino group at the same carbon atom which makes them versatile building blocks for the synthesis of various heterocycles. Their importance in chemistry along with their rich biology, make amidoximes an attractive target for medicinal chemists, biochemists and biologists. Amidoximes and simple O-substituted derivatives possess very important biological activities functioning as antituberculotic, antibacterial, bacteriostatic, insecticidal, elminthicidal, antiviral, herbicidal, fungicidal, antineoplastic, antiarrythmic, antihypertensive, antihistaminic, anxiolytic-antidepressant, anti-inflammatory/antioxidant, antiaggregatory (NO donors) or plant growth regulatory agents. A number of amidoximes has already been used as drugs, or currently being in clinical trials. Their numerous pharmaceutical applications have been recently enriched, due to the fact that some mechanistic pathways, concerning their conversion to amidines, as well as their ability to release NO were clarified, giving a new insight to their mode of action and allowing the design of new therapeutic agents. The main subject of the present review paper is to highlight aspects concerning chemical and biological questions on this interesting class of compounds. Some new synthetic methodologies as well as improvements of previously reported general reactions involving amidoximes, acylated amidoximes, and amidines are presented. The biological applications of amidoximes over the end of 2006 are also extensively reviewed.

show abstract

Section: Iv11 Anxiolytics-antidepressantsmentioning

confidence: 99%